HFE-Related Hemochromatosis in a Chinese Patient: The First Reported Case

HFE-related Hemochromatosis is the most common genetic iron overload disease in European populations, particularly of Nordic or Celtic ancestry. It is reported that the HFE p.C282Y mutation is present in 1/10 people of northern European descent, resulting in one in two hundred people will be homozyg...

Full description

Bibliographic Details
Main Authors: Wei Zhang, Xiaoming Wang, Weijia Duan, Anjian Xu, Xinyan Zhao, Jian Huang, Hong You, Pierre Brissot, Xiaojuan Ou, Jidong Jia
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fgene.2020.00077/full
_version_ 1818600247092314112
author Wei Zhang
Wei Zhang
Wei Zhang
Xiaoming Wang
Xiaoming Wang
Xiaoming Wang
Weijia Duan
Weijia Duan
Weijia Duan
Anjian Xu
Anjian Xu
Anjian Xu
Xinyan Zhao
Xinyan Zhao
Xinyan Zhao
Jian Huang
Jian Huang
Jian Huang
Jian Huang
Hong You
Hong You
Hong You
Pierre Brissot
Xiaojuan Ou
Xiaojuan Ou
Xiaojuan Ou
Jidong Jia
Jidong Jia
Jidong Jia
author_facet Wei Zhang
Wei Zhang
Wei Zhang
Xiaoming Wang
Xiaoming Wang
Xiaoming Wang
Weijia Duan
Weijia Duan
Weijia Duan
Anjian Xu
Anjian Xu
Anjian Xu
Xinyan Zhao
Xinyan Zhao
Xinyan Zhao
Jian Huang
Jian Huang
Jian Huang
Jian Huang
Hong You
Hong You
Hong You
Pierre Brissot
Xiaojuan Ou
Xiaojuan Ou
Xiaojuan Ou
Jidong Jia
Jidong Jia
Jidong Jia
author_sort Wei Zhang
collection DOAJ
description HFE-related Hemochromatosis is the most common genetic iron overload disease in European populations, particularly of Nordic or Celtic ancestry. It is reported that the HFE p.C282Y mutation is present in 1/10 people of northern European descent, resulting in one in two hundred people will be homozygous. However, the HFE p.C282Y heterozygosity is virtually absent among East Asians, including Japanese, Koreans, and Chinese. In this article, we report a case of HFE-related hemochromatosis caused by compound heterozygosity HFE p.C282Y/p.R71X. This is the first report of hemochromatosis associated with HFE p.C282Y mutation in China.
first_indexed 2024-12-16T12:32:27Z
format Article
id doaj.art-c194f4d027a148b98e5e2f4bdd5ae695
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-12-16T12:32:27Z
publishDate 2020-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-c194f4d027a148b98e5e2f4bdd5ae6952022-12-21T22:31:40ZengFrontiers Media S.A.Frontiers in Genetics1664-80212020-02-011110.3389/fgene.2020.00077505459HFE-Related Hemochromatosis in a Chinese Patient: The First Reported CaseWei Zhang0Wei Zhang1Wei Zhang2Xiaoming Wang3Xiaoming Wang4Xiaoming Wang5Weijia Duan6Weijia Duan7Weijia Duan8Anjian Xu9Anjian Xu10Anjian Xu11Xinyan Zhao12Xinyan Zhao13Xinyan Zhao14Jian Huang15Jian Huang16Jian Huang17Jian Huang18Hong You19Hong You20Hong You21Pierre Brissot22Xiaojuan Ou23Xiaojuan Ou24Xiaojuan Ou25Jidong Jia26Jidong Jia27Jidong Jia28Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Beijing, ChinaClinical Research Center for Rare Liver Diseases, Capital Medical University, Beijing, ChinaLiver Research Center, National Clinical Research Center for Digestive Diseases, Beijing, ChinaLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Beijing, ChinaClinical Research Center for Rare Liver Diseases, Capital Medical University, Beijing, ChinaLiver Research Center, National Clinical Research Center for Digestive Diseases, Beijing, ChinaLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Beijing, ChinaClinical Research Center for Rare Liver Diseases, Capital Medical University, Beijing, ChinaLiver Research Center, National Clinical Research Center for Digestive Diseases, Beijing, ChinaLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Beijing, ChinaLiver Research Center, National Clinical Research Center for Digestive Diseases, Beijing, ChinaExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Beijing, ChinaClinical Research Center for Rare Liver Diseases, Capital Medical University, Beijing, ChinaLiver Research Center, National Clinical Research Center for Digestive Diseases, Beijing, ChinaLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Beijing, ChinaClinical Research Center for Rare Liver Diseases, Capital Medical University, Beijing, ChinaLiver Research Center, National Clinical Research Center for Digestive Diseases, Beijing, ChinaExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Beijing, ChinaClinical Research Center for Rare Liver Diseases, Capital Medical University, Beijing, ChinaLiver Research Center, National Clinical Research Center for Digestive Diseases, Beijing, ChinaInstitut NuMeCan, InsermU-1241, University of Rennes1, Rennes, FranceLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Beijing, ChinaClinical Research Center for Rare Liver Diseases, Capital Medical University, Beijing, ChinaLiver Research Center, National Clinical Research Center for Digestive Diseases, Beijing, ChinaLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Beijing, ChinaClinical Research Center for Rare Liver Diseases, Capital Medical University, Beijing, ChinaLiver Research Center, National Clinical Research Center for Digestive Diseases, Beijing, ChinaHFE-related Hemochromatosis is the most common genetic iron overload disease in European populations, particularly of Nordic or Celtic ancestry. It is reported that the HFE p.C282Y mutation is present in 1/10 people of northern European descent, resulting in one in two hundred people will be homozygous. However, the HFE p.C282Y heterozygosity is virtually absent among East Asians, including Japanese, Koreans, and Chinese. In this article, we report a case of HFE-related hemochromatosis caused by compound heterozygosity HFE p.C282Y/p.R71X. This is the first report of hemochromatosis associated with HFE p.C282Y mutation in China.https://www.frontiersin.org/article/10.3389/fgene.2020.00077/fullHFEcompound heterozygosityhemochromatosisiron overloadChinese
spellingShingle Wei Zhang
Wei Zhang
Wei Zhang
Xiaoming Wang
Xiaoming Wang
Xiaoming Wang
Weijia Duan
Weijia Duan
Weijia Duan
Anjian Xu
Anjian Xu
Anjian Xu
Xinyan Zhao
Xinyan Zhao
Xinyan Zhao
Jian Huang
Jian Huang
Jian Huang
Jian Huang
Hong You
Hong You
Hong You
Pierre Brissot
Xiaojuan Ou
Xiaojuan Ou
Xiaojuan Ou
Jidong Jia
Jidong Jia
Jidong Jia
HFE-Related Hemochromatosis in a Chinese Patient: The First Reported Case
Frontiers in Genetics
HFE
compound heterozygosity
hemochromatosis
iron overload
Chinese
title HFE-Related Hemochromatosis in a Chinese Patient: The First Reported Case
title_full HFE-Related Hemochromatosis in a Chinese Patient: The First Reported Case
title_fullStr HFE-Related Hemochromatosis in a Chinese Patient: The First Reported Case
title_full_unstemmed HFE-Related Hemochromatosis in a Chinese Patient: The First Reported Case
title_short HFE-Related Hemochromatosis in a Chinese Patient: The First Reported Case
title_sort hfe related hemochromatosis in a chinese patient the first reported case
topic HFE
compound heterozygosity
hemochromatosis
iron overload
Chinese
url https://www.frontiersin.org/article/10.3389/fgene.2020.00077/full
work_keys_str_mv AT weizhang hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT weizhang hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT weizhang hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT xiaomingwang hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT xiaomingwang hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT xiaomingwang hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT weijiaduan hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT weijiaduan hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT weijiaduan hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT anjianxu hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT anjianxu hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT anjianxu hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT xinyanzhao hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT xinyanzhao hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT xinyanzhao hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT jianhuang hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT jianhuang hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT jianhuang hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT jianhuang hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT hongyou hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT hongyou hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT hongyou hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT pierrebrissot hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT xiaojuanou hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT xiaojuanou hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT xiaojuanou hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT jidongjia hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT jidongjia hferelatedhemochromatosisinachinesepatientthefirstreportedcase
AT jidongjia hferelatedhemochromatosisinachinesepatientthefirstreportedcase